Dr. Scott E. Delacroix
Claim this profileLSU Healthcare Network / Metairie Multi-Specialty Clinic
Expert in Prostate Cancer
Studies Bladder Cancer
28 reported clinical trials
63 drugs studied
About Scott E. Delacroix
Education:
- Received MD (Doctor of Medicine) from Louisiana State University School of Medicine, New Orleans, in 1987.
Experience:
- Board Certified in Internal Medicine by the American Board of Internal Medicine.
- Currently practicing at LSU Healthcare Network / Metairie Multi-Specialty Clinic.
Area of expertise
1Prostate Cancer
Global LeaderStage IV
synaptophysin positive
chromogranin positive
2Bladder Cancer
Stage IV
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Scott E. Delacroix is currently running
Radium-223 + Cabozantinib
for Kidney Cancer with Bone Metastasis
This phase II trial studies whether adding radium-223 dichloride to the usual treatment, cabozantinib, improves outcomes in patients with renal cell cancer that has spread to the bone. Radioactive drugs such as radium-223 dichloride may directly target radiation to cancer cells and minimize harm to normal cells. Cabozantinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving radium-223 dichloride and cabozantinib may help lessen the pain and symptoms from renal cell cancer that has spread to the bone, compared to cabozantinib alone.
Recruiting1 award Phase 216 criteria
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
More about Scott E. Delacroix
Clinical Trial Related5 years of experience running clinical trials · Led 28 trials as a Principal Investigator · 13 Active Clinical TrialsTreatments Scott E. Delacroix has experience with
- Gemcitabine Hydrochloride
- Radiation Therapy
- Bicalutamide
- Flutamide
- Atezolizumab
- Docetaxel
Breakdown of trials Scott E. Delacroix has run
Prostate Cancer
Bladder Cancer
Prostate Adenocarcinoma
Kidney Cancer
Urothelial Carcinoma
- Immune Checkpoint Therapy Duration for Bladder Cancer
- Durvalumab + Chemotherapy for Urothelial Carcinoma
- Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott E. Delacroix specialize in?
Scott E. Delacroix focuses on Prostate Cancer and Bladder Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are synaptophysin positive.
Is Scott E. Delacroix currently recruiting for clinical trials?
Yes, Scott E. Delacroix is currently recruiting for 13 clinical trials in Metairie Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Scott E. Delacroix has studied deeply?
Yes, Scott E. Delacroix has studied treatments such as Gemcitabine Hydrochloride, Radiation Therapy, Bicalutamide.
What is the best way to schedule an appointment with Scott E. Delacroix?
Apply for one of the trials that Scott E. Delacroix is conducting.
What is the office address of Scott E. Delacroix?
The office of Scott E. Delacroix is located at: LSU Healthcare Network / Metairie Multi-Specialty Clinic, Metairie, Louisiana 70006 United States. This is the address for their practice at the LSU Healthcare Network / Metairie Multi-Specialty Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.